Protective effect of the natural product, chaetoglobosin K, on lindane- and dieldrin-induced changes in astroglia: identification of activated signaling pathways.
OBJECTIVE
The purpose of the present study was to identify the biochemical mechanism(s) of the preventative and reversal effects of Chaetoglobosin K (ChK), a bioactive natural product, on inhibition of gap junction-mediated communication and connexin phosphorylation by the tumor promoting organochlorine compounds, lindane, and dieldrin.


METHODS
A fluorescent dye transfer assay was used to quantify gap junction-mediated communication and sensitivity to lindane and dieldrin. Analyses of connexin 43, PKC, ERK, GSK-3beta, Raf, and Akt kinase phosphorylation were performed by Western blotting.


RESULTS
Pre-incubation of astroglial cells with 10 microM ChK prevented inhibition of dye transfer by lindane and dieldrin, which correlates with stabilization of the connexin 43 P2 isoform, and addition of ChK after lindane or dieldrin reversed the inhibitory effect, which correlated with re-appearance of the P2 isoform. Using phosphorylation site-specific antibodies, we demonstrated that lindane, dieldrin, and ChK all activated p44/42 ERK, but only ChK activated Akt kinase. ChK also activated a downstream effector of Akt, GSK-3beta, and activation of both kinases was inhibited by Wortmannin. Wortmannin also blocked ChK's ability to prevent dieldrin-induced inhibition of gap junction-mediated communication between RG-2 cells.


CONCLUSIONS
ChK's protective effects, both preventative and reversal, on lindane and dieldrin inhibition of gap junction-mediated communication are associated with stabilization and reappearance of the connexin 43 P2 phosphoform and may be mediated by the Akt pathway.
Department of Pharmaceutical Sciences, Mercer University, Atlanta, GA 30341, USA.
Tatyana S
TS
Sidorova
Diane F
DF
Matesic
D000818:Animals; D001253:Astrocytes / Q000187:drug effects*; D002450:Cell Communication / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D018031:Connexin 43 / Q000378:metabolism; D004026:Dieldrin / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D001556:Hexachlorocyclohexane / Q000633:toxicity*; D026121:Indole Alkaloids / Q000494:pharmacology*; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects*
D018031:Connexin 43; D026121:Indole Alkaloids; D018696:Neuroprotective Agents; C019290:chaetoglobosins; D001556:Hexachlorocyclohexane; D051057:Proto-Oncogene Proteins c-akt; D004026:Dieldrin